Supply Chains Don’t Fail Gracefully.
When a critical supplier can’t deliver, MedTech OEMs face impossible choices. Production schedules slip. Costs increase overnight. Risk multiplies— across quality, compliance, and patients.
The real risk isn’t just supply but accountability. For operations and supply chain leaders, it means answering hard questions internally, protecting customers externally, and ensuring patients are never impacted—often under intense time pressure.
In this case, an OEM relied on two critical components for their device. When an incumbent vendor encountered serious supply issues, the OEM’s entire production plan was suddenly exposed. They needed a solution, and fast. But one that wouldn’t create new risks downstream.
They needed a partner who could move quickly without compromising control, quality, or long-term strategy.
Rather than scrambling for a short-term fix, the OEM sought a CDMO experienced in:
- Rapid tooling transfer,
- Advanced plastics processing,
- Regulated MedTech manufacturing, and
- Scalable U.S. and nearshore production.
The objective wasn’t just to restore supply— it was to redesign the supply chain for resilience.
Step 1: Immediate Stabilization
Tooling and production were transferred quickly to one of our manufacturing facilities in the U.S. to protect supply continuity and meet near-term demand.
Step 2: Tooling & Process Optimization
Engineering and manufacturing teams evaluated tooling, processes, and yields— implementing improvements to enhance consistency, efficiency, and scalability.
Step 3: Strategic Transition to the Dominican Republic
Once stabilized, production was transitioned to our low-cost, nearshore facility in Santo Domingo, the Dominican Republic— reducing cost while maintaining quality, compliance, and delivery performance.
This wasn’t a lift-and-shift. It worked because as a strategic manufacturing partner we were able:
- Build and modify tooling in-house;
- Control the process from toolroom to production floor;
- Scale manufacturing across geographies without disruption; and
- Maintain regulatory rigor throughout the transition.
The result was a controlled, predictable transformation, not a risky handoff.
What began as a supply disruption became an opportunity to build a stronger, more resilient manufacturing strategy— one designed for growth, not just recovery.
YOUR SUPPLY CHAIN DOESN’T HAVE TO BE FRAGILE
If a key supplier failed tomorrow, would your organization be ready? Learn how one MedTech OEM turned disruption into advantage— and what the same approach could look like for your supply chain. Download the case study.
